Cargando…
Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis
Lung cancer accounts for the highest number of deaths among men and women worldwide. Although extensive therapies, either alone or in conjunction with some specific drugs, continue to be the principal regimen for evolving lung cancer, significant improvements are still needed to understand the inher...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604646/ https://www.ncbi.nlm.nih.gov/pubmed/37893079 http://dx.doi.org/10.3390/biomedicines11102706 |
_version_ | 1785126884427694080 |
---|---|
author | Khilwani, Riya Singh, Shailza |
author_facet | Khilwani, Riya Singh, Shailza |
author_sort | Khilwani, Riya |
collection | PubMed |
description | Lung cancer accounts for the highest number of deaths among men and women worldwide. Although extensive therapies, either alone or in conjunction with some specific drugs, continue to be the principal regimen for evolving lung cancer, significant improvements are still needed to understand the inherent biology behind progressive inflammation and its detection. Unfortunately, despite every advancement in its treatment, lung cancer patients display different growth mechanisms and continue to die at significant rates. Autophagy, which is a physiological defense mechanism, serves to meet the energy demands of nutrient-deprived cancer cells and sustain the tumor cells under stressed conditions. In contrast, autophagy is believed to play a dual role during different stages of tumorigenesis. During early stages, it acts as a tumor suppressor, degrading oncogenic proteins; however, during later stages, autophagy supports tumor cell survival by minimizing stress in the tumor microenvironment. The pivotal role of the IL6-IL17-IL23 signaling axis has been observed to trigger autophagic events in lung cancer patients. Since the obvious roles of autophagy are a result of different immune signaling cascades, systems biology can be an effective tool to understand these interconnections and enhance cancer treatment and immunotherapy. In this review, we focus on how systems biology can be exploited to target autophagic processes that resolve inflammatory responses and contribute to better treatment in carcinogenesis. |
format | Online Article Text |
id | pubmed-10604646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106046462023-10-28 Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis Khilwani, Riya Singh, Shailza Biomedicines Review Lung cancer accounts for the highest number of deaths among men and women worldwide. Although extensive therapies, either alone or in conjunction with some specific drugs, continue to be the principal regimen for evolving lung cancer, significant improvements are still needed to understand the inherent biology behind progressive inflammation and its detection. Unfortunately, despite every advancement in its treatment, lung cancer patients display different growth mechanisms and continue to die at significant rates. Autophagy, which is a physiological defense mechanism, serves to meet the energy demands of nutrient-deprived cancer cells and sustain the tumor cells under stressed conditions. In contrast, autophagy is believed to play a dual role during different stages of tumorigenesis. During early stages, it acts as a tumor suppressor, degrading oncogenic proteins; however, during later stages, autophagy supports tumor cell survival by minimizing stress in the tumor microenvironment. The pivotal role of the IL6-IL17-IL23 signaling axis has been observed to trigger autophagic events in lung cancer patients. Since the obvious roles of autophagy are a result of different immune signaling cascades, systems biology can be an effective tool to understand these interconnections and enhance cancer treatment and immunotherapy. In this review, we focus on how systems biology can be exploited to target autophagic processes that resolve inflammatory responses and contribute to better treatment in carcinogenesis. MDPI 2023-10-05 /pmc/articles/PMC10604646/ /pubmed/37893079 http://dx.doi.org/10.3390/biomedicines11102706 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khilwani, Riya Singh, Shailza Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis |
title | Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis |
title_full | Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis |
title_fullStr | Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis |
title_full_unstemmed | Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis |
title_short | Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis |
title_sort | systems biology and cytokines potential role in lung cancer immunotherapy targeting autophagic axis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604646/ https://www.ncbi.nlm.nih.gov/pubmed/37893079 http://dx.doi.org/10.3390/biomedicines11102706 |
work_keys_str_mv | AT khilwaniriya systemsbiologyandcytokinespotentialroleinlungcancerimmunotherapytargetingautophagicaxis AT singhshailza systemsbiologyandcytokinespotentialroleinlungcancerimmunotherapytargetingautophagicaxis |